10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 432,508 | 397,712 | 377,061 | 344,067 | 398,159 |
| Marketable Securities | 49,576 | 49,549 | 49,844 | 49,335 | N/A |
| Receivables | 96,592 | 119,067 | 52,549 | 88,468 | 83,525 |
| Inventories | 61,956 | 68,968 | 74,710 | 83,107 | 94,050 |
| TOTAL | $659,827 | $655,661 | $579,730 | $584,387 | $593,893 |
| Non-Current Assets | |||||
| PPE Net | 232,534 | 239,710 | 246,087 | 252,648 | 258,759 |
| Intangibles | 69,270 | 19,225 | 19,703 | 20,182 | 20,660 |
| Other Non-Current Assets | 65,730 | 65,374 | 57,873 | 61,419 | 64,482 |
| TOTAL | $367,534 | $324,309 | $323,663 | $334,249 | $343,901 |
| Total Assets | $1,027,361 | $979,970 | $903,393 | $918,636 | $937,794 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,069 | 15,938 | 10,068 | 12,909 | 26,210 |
| Accrued Expenses | 72,850 | 65,165 | 67,440 | 74,780 | 67,850 |
| Other current liabilities | 23,723 | N/A | N/A | N/A | N/A |
| TOTAL | $147,324 | $112,221 | $107,900 | $117,633 | $121,235 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 22,139 | 21,449 | 20,949 | 20,658 | 17,760 |
| Other Non-Current Liabilities | 84,046 | 83,200 | 76,029 | 78,356 | 81,406 |
| TOTAL | $94,917 | $94,470 | $88,598 | $90,869 | $93,755 |
| Total Liabilities | $242,241 | $206,691 | $196,498 | $208,502 | $214,990 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 126,553 | 124,490 | 123,134 | 122,302 | 121,054 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,494,339 | -1,466,867 | -1,501,405 | -1,467,047 | -1,418,019 |
| Other shareholders' equity | 138 | 220 | -367 | -493 | 32 |
| TOTAL | $785,120 | $773,279 | $706,895 | $710,134 | $722,804 |
| Total Liabilities And Equity | $1,027,361 | $979,970 | $903,393 | $918,636 | $937,794 |